UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

Incidence of venous thromboembolism following major surgery in Korea: from the Health Insurance Review and Assessment Service database

Journal of thrombosis and haemostasis, 2014-07, Vol.12 (7), p.1035-1043

2014

Link zum Volltext

Verfügbarkeit prüfen

Combination treatment of copanlisib and gemcitabine in relapsed/refractory PTCL (COSMOS): an open-label phase I/II trial

Annals of oncology, 2021-04, Vol.32 (4), p.552-559

2021

Link zum Volltext

Verfügbarkeit prüfen

Venous thromboembolism following L‐asparaginase treatment for lymphoid malignancies in Korea

Journal of thrombosis and haemostasis, 2017-04, Vol.15 (4), p.655-661

2017

Link zum Volltext

Verfügbarkeit prüfen

Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia

Annals of oncology, 2016-06, Vol.27 (6), p.1081-1088

2016

Link zum Volltext

Verfügbarkeit prüfen

Matched-pair analysis to compare the outcomes of a second salvage auto-SCT to systemic chemotherapy alone in patients with multiple myeloma who relapsed after front-line auto-SCT

Bone marrow transplantation (Basingstoke), 2013-03, Vol.48 (3), p.425-432

2013

Link zum Volltext

Verfügbarkeit prüfen

Linear IgA bullous dermatosis following autologous PBSC transplantation in a patient with non-Hodgkin's lymphoma

Bone marrow transplantation (Basingstoke), 2011-01, Vol.46 (1), p.156-158

2011

Link zum Volltext

Verfügbarkeit prüfen

PS956 A MULTICENTER, RETROSPECTIVE STUDY TO EVALUATE EFFICACY AND SAFETY OF BUSULFAN/FLUDARABINE CONDITIONING FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

HemaSphere, 2019-06, Vol.3 (S1), p.430-431

2019

Link zum Volltext

Verfügbarkeit prüfen

Copanlisib plus Gemcitabine Has Efficacy in Peripheral T-cell Lymphomas

Cancer discovery, 2021-05, Vol.11 (5), p.1007-1007

2021

Link zum Volltext

Verfügbarkeit prüfen

The role of frontline autologous stem cell transplantation for primary plasma cell leukemia: a retrospective multicenter study (KMM160)

Oncotarget, 2017-10, Vol.8 (45), p.79517-79526

2017

Link zum Volltext

Verfügbarkeit prüfen

Use of curcumin to decrease nitric oxide production during the induction of antitumor responses by IL-2

Journal of immunotherapy (1997), 2011-03, Vol.34 (2), p.149

2011

Link zum Volltext

Verfügbarkeit prüfen

Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpura

Blood Research, 2019, 54(3), , pp.218-228

2019

Link zum Volltext

Verfügbarkeit prüfen

PS1108 CLINICAL FEATURES AND TREATMENT OUTCOMES OF ACQUIRED HEMOPHILIA A IN KOREA: RETROSPECTIVE ANALYSIS

HemaSphere, 2019-06, Vol.3 (S1), p.502-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

ABO blood types are associated with risk of idiopathic venous thromboembolism in the Korean population. A report from the Korean Venous Thromboembolism Working Party (KVTEWP)

Thrombosis and haemostasis, 2012-04, Vol.107 (4), p.799

2012

Link zum Volltext

Verfügbarkeit prüfen

Linear IgA bullous dermatosis following autologous PBSC transplantation in a patient with non-Hodgkin's lymphoma

Bone marrow transplantation, 2011, Vol.46 (1), p.156-158

2011

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study

BMC cancer, 2010-06, Vol.10 (1), p.321-321, Article 321

2010

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of interim 11C‐methionine PET for the treatment of primary central nervous system lymphoma (PCNSL)

Hematological oncology, 2017-06, Vol.35 (S2), p.302-302

2017

Link zum Volltext

Verfügbarkeit prüfen

Ibrutinib in Combination with Ifosfamide, Etoposide, and Rituximab Followed by Ibrutinib Maintenance Therapy in Patients with R/R‐PCNSL: A Multicenter Phase II Study

Hematological oncology, 2023-06, Vol.41 (S2), p.400-400

2023

Link zum Volltext

Verfügbarkeit prüfen

PROSPECTIVE KOREAN MARGINAL ZONE LYMPHOMAS COHORT STUDY: INITIAL DATA ANALYSIS OF 407 CASES

Hematological oncology, 2023-06, Vol.41 (S2), p.686-686

2023

Link zum Volltext

Verfügbarkeit prüfen

RANDOMIZED PHASE II STUDY OF CHOP VS. FRACTIONATED ICED IN TRANSPLANT‐ELIGIBLE PATIENTS WITH PREVIOUSLY UNTREATED PERIPHERAL T‐CELL LYMPHOMA: INTERIM RESULTS OF CISL1504

Hematological oncology, 2019-06, Vol.37 (S2), p.467-468

2019

Link zum Volltext

Verfügbarkeit prüfen

A randomized phase II trial of CHOP versus ICED and autologous stem cell transplantation in newly diagnosed T‐cell lymphoma

Hematological oncology, 2023-06, Vol.41 (S2), p.497-499

2023

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of interim 11 C ‐methionine PET for the treatment of primary central nervous system lymphoma ( PCNSL )

Hematological oncology, 2017-06, Vol.35 (S2), p.302-302

2017

Link zum Volltext

Verfügbarkeit prüfen

RISK STRATIFICATION BASED ON NCCN‐IPI AT THE TIME OF DIAGNOSIS IN COMBINATION WITH POST‐TREATMENT PET‐CT SCAN FOR THE TREATMENT OF NODAL PERIPHERAL T‐CELL LYMPHOMA

Hematological oncology, 2017-06, Vol.35 (S2), p.243-244

2017

Link zum Volltext

Verfügbarkeit prüfen

The prognostic factors for the recurred breast cancer patients with isolated, limited number of lung metastasis, and the implication of pulmonary metastasectomy

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.1112-1112

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(22)
Berichte
(1)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

7 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Incidence of venous thromboembolism following major surgery in Korea: from the Health Insurance Review and Assessment Service database

Combination treatment of copanlisib and gemcitabine in relapsed/refractory PTCL (COSMOS): an open-label phase I/II trial

Venous thromboembolism following L‐asparaginase treatment for lymphoid malignancies in Korea

Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia

Matched-pair analysis to compare the outcomes of a second salvage auto-SCT to systemic chemotherapy alone in patients with multiple myeloma who relapsed after front-line auto-SCT

Linear IgA bullous dermatosis following autologous PBSC transplantation in a patient with non-Hodgkin's lymphoma

PS956 A MULTICENTER, RETROSPECTIVE STUDY TO EVALUATE EFFICACY AND SAFETY OF BUSULFAN/FLUDARABINE CONDITIONING FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

Copanlisib plus Gemcitabine Has Efficacy in Peripheral T-cell Lymphomas

The role of frontline autologous stem cell transplantation for primary plasma cell leukemia: a retrospective multicenter study (KMM160)

Use of curcumin to decrease nitric oxide production during the induction of antitumor responses by IL-2

Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpura

PS1108 CLINICAL FEATURES AND TREATMENT OUTCOMES OF ACQUIRED HEMOPHILIA A IN KOREA: RETROSPECTIVE ANALYSIS

ABO blood types are associated with risk of idiopathic venous thromboembolism in the Korean population. A report from the Korean Venous Thromboembolism Working Party (KVTEWP)

Linear IgA bullous dermatosis following autologous PBSC transplantation in a patient with non-Hodgkin's lymphoma

Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study

Prognostic significance of interim 11C‐methionine PET for the treatment of primary central nervous system lymphoma (PCNSL)

Ibrutinib in Combination with Ifosfamide, Etoposide, and Rituximab Followed by Ibrutinib Maintenance Therapy in Patients with R/R‐PCNSL: A Multicenter Phase II Study

PROSPECTIVE KOREAN MARGINAL ZONE LYMPHOMAS COHORT STUDY: INITIAL DATA ANALYSIS OF 407 CASES

RANDOMIZED PHASE II STUDY OF CHOP VS. FRACTIONATED ICED IN TRANSPLANT‐ELIGIBLE PATIENTS WITH PREVIOUSLY UNTREATED PERIPHERAL T‐CELL LYMPHOMA: INTERIM RESULTS OF CISL1504

A randomized phase II trial of CHOP versus ICED and autologous stem cell transplantation in newly diagnosed T‐cell lymphoma

Prognostic significance of interim 11 C ‐methionine PET for the treatment of primary central nervous system lymphoma ( PCNSL )

RISK STRATIFICATION BASED ON NCCN‐IPI AT THE TIME OF DIAGNOSIS IN COMBINATION WITH POST‐TREATMENT PET‐CT SCAN FOR THE TREATMENT OF NODAL PERIPHERAL T‐CELL LYMPHOMA

The prognostic factors for the recurred breast cancer patients with isolated, limited number of lung metastasis, and the implication of pulmonary metastasectomy

Suchergebnisse filtern